Tau is expressed in several cancer cells (Gargini et al., 2019), and the different actions of lonafarnib in WTau and PTau cells observed in the present study suggested that the evaluation of Tau and its phosphorylation might be valuable for the development of cancer treatments. This evidence concerns the gene MAPT and cancer.